Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GSK plc (GSK) vs Riot Platforms Inc (RIOT) Price & Performance

Riot Platforms IncTrade

Price performance (Past 24H)

Key statistics

GSK plc vs Riot Platforms Inc — how do they compare? GSK plc trades at $50.54 (market cap $101.13B), while Riot Platforms Inc trades at $20.25 (market cap $7.63B). The key difference: GSK plc is far larger — about 13.3× Riot Platforms Inc's market cap, and GSK plc pays a 3.61% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals.

GSKRIOT
Market Cap
$101.13B$7.63B
Sector
HealthTechnology
52-Week High
$61.18$28.67
52-Week Low
$38.96$11.33
Enterprise Value
$121.57B$8.03B
Dividend Yield
3.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GSK plc

GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.

The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.

Riot Platforms Inc

RIOT Platforms trades at $20.32, up 4.74% today, amid strong technical resistance near $21-$23 levels. The stock shows bearish momentum despite recent positive news about a $9.1 billion AI infrastructure deal with Anthropic. Fundamentally, the company continues to post significant losses with a -196.28% net income margin, though revenue growth remains steady at $675 million projected for 2026.

While analyst consensus remains overwhelmingly bullish with a $33.40 price target, investors face substantial execution risks as RIOT transitions from bitcoin mining to AI infrastructure. The company's persistent negative cash flow and high valuation multiples present challenges despite the transformative potential of the Anthropic partnership.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK

About Riot Platforms Inc

Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.

Read more on RIOT